Arnold Kloos

1.5k total citations
27 papers, 630 citations indexed

About

Arnold Kloos is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Arnold Kloos has authored 27 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Hematology. Recurrent topics in Arnold Kloos's work include Acute Myeloid Leukemia Research (12 papers), Virus-based gene therapy research (10 papers) and CAR-T cell therapy research (10 papers). Arnold Kloos is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Virus-based gene therapy research (10 papers) and CAR-T cell therapy research (10 papers). Arnold Kloos collaborates with scholars based in Germany, United States and United Kingdom. Arnold Kloos's co-authors include Florian Kühnel, Norman Woller, Michael P. Manns, Engin Gürlevik, Thomas Wirth, Stefan Kubicka, Sarah Knocke, Bettina Fleischmann-Mundt, Michael Heuser and Robert Geffers and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Arnold Kloos

25 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnold Kloos Germany 14 408 276 241 220 85 27 630
Jessica Wenthe Sweden 11 611 1.5× 312 1.1× 315 1.3× 225 1.0× 19 0.2× 24 799
Dirk M. van der Steen Netherlands 14 440 1.1× 145 0.5× 432 1.8× 283 1.3× 109 1.3× 28 747
Thomas Leemhuis United States 10 295 0.7× 160 0.6× 204 0.8× 195 0.9× 123 1.4× 13 555
Tomoyuki Ogura Japan 11 157 0.4× 96 0.3× 330 1.4× 120 0.5× 101 1.2× 28 558
D Banerjee United States 10 186 0.5× 172 0.6× 74 0.3× 348 1.6× 85 1.0× 14 555
Maxine Bauzon United States 12 361 0.9× 397 1.4× 77 0.3× 303 1.4× 23 0.3× 25 606
Anthony F. Daniyan United States 12 784 1.9× 237 0.9× 363 1.5× 326 1.5× 139 1.6× 24 1.0k
Uxua Mancheño Spain 14 343 0.8× 164 0.6× 350 1.5× 192 0.9× 13 0.2× 19 623
Peter Buttgereit Germany 11 239 0.6× 138 0.5× 264 1.1× 215 1.0× 30 0.4× 14 523
Teresa Rasalan United States 12 742 1.8× 77 0.3× 953 4.0× 293 1.3× 72 0.8× 17 1.2k

Countries citing papers authored by Arnold Kloos

Since Specialization
Citations

This map shows the geographic impact of Arnold Kloos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Kloos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Kloos more than expected).

Fields of papers citing papers by Arnold Kloos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold Kloos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Kloos. The network helps show where Arnold Kloos may publish in the future.

Co-authorship network of co-authors of Arnold Kloos

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold Kloos. A scholar is included among the top collaborators of Arnold Kloos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold Kloos. Arnold Kloos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kloos, Arnold, Robert Geffers, Kerstin Görlich, et al.. (2025). XPO1-dependency of DEK::NUP214 leukemia. Leukemia. 39(5). 1102–1113.
2.
Georgiadis, Christos, Arnold Kloos, Amit D. Joshi, et al.. (2025). Base edited “universal” donor CAR T-cell strategies for acute myeloid leukaemia. Leukemia. 39(12). 2978–2987.
3.
Gabdoulline, Razif, Rabia Shahswar, Arnold Kloos, et al.. (2024). Prognostic Impact of Subclinical FLT3-ITD Microclones in Patients with Acute Myeloid Leukemia. Blood. 144(Supplement 1). 847–847. 1 indexed citations
4.
Shahswar, Rabia, Gernot Beutel, Razif Gabdoulline, et al.. (2023). Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia. Haematologica. 109(1). 72–83. 10 indexed citations
5.
Kloos, Arnold, Max Ettinger, Tim Kacprowski, et al.. (2023). A 19‐color single‐tube full spectrum flow cytometry assay for the detection of measurable residual disease in acute myeloid leukemia. Cytometry Part A. 105(3). 181–195. 7 indexed citations
6.
Kloos, Arnold, Christos Georgiadis, Annie Etuk, et al.. (2022). Single and Combinational Multiplex Base-Edited 'Universal' CAR T Cells in a Humanised Model of Primary CD7+CD33+ AML. Blood. 140(Supplement 1). 7425–7426. 4 indexed citations
7.
Morgan, Michael, Arnold Kloos, Katharina Zimmermann, et al.. (2021). Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123. Viruses. 13(7). 1365–1365. 26 indexed citations
8.
Kloos, Arnold, Razif Gabdoulline, Nidhi Jyotsana, et al.. (2020). Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia. Leukemia. 34(11). 2951–2963. 9 indexed citations
9.
Woller, Norman, Jennifer D. Brooks, Bettina Fleischmann-Mundt, et al.. (2019). Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy. Nature Communications. 10(1). 3236–3236. 52 indexed citations
10.
Kloeß, Stephan, Olaf Oberschmidt, Arnold Kloos, et al.. (2019). Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer–Based “Off-the-Shelf” Acute Myeloid Leukemia Immunotherapies. Human Gene Therapy. 30(4). 381–401. 44 indexed citations
11.
Chaturvedi, Anuhar, Charu Gupta, Michelle Cruz, et al.. (2019). In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site. Leukemia. 34(2). 416–426. 14 indexed citations
12.
Scherr, Michaela, Karin Battmer, Melanie Ricke‐Hoch, et al.. (2018). Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia. Leukemia. 33(6). 1313–1323. 14 indexed citations
13.
Adams, Felix F., Dirk Heckl, Thomas Hoffmann, et al.. (2017). An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries. Biomaterials. 139. 102–115. 15 indexed citations
14.
Kloos, Arnold, Norman Woller, Rita Gerardy‐Schahn, & Florian Kühnel. (2015). Retargeted oncolytic viruses provoke tumor-directed T-cell responses. OncoImmunology. 4(12). e1052933–e1052933. 10 indexed citations
15.
Woller, Norman, Engin Gürlevik, Bettina Fleischmann-Mundt, et al.. (2015). Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses. Molecular Therapy. 23(10). 1630–1640. 162 indexed citations
16.
Gürlevik, Engin, Bettina Fleischmann-Mundt, Thomas Longerich, et al.. (2013). Adjuvant Gemcitabine Therapy Improves Survival in A Locally Induced, R0-Resectable Model of Metastatic Intrahepatic Cholangiocarcinoma. Hepatology. 58(3). 1031–1041. 31 indexed citations
17.
Gürlevik, Engin, Arnold Kloos, Norman Woller, et al.. (2013). Meganuclease-mediated Virus Self-cleavage Facilitates Tumor-specific Virus Replication. Molecular Therapy. 21(9). 1738–1748. 5 indexed citations
18.
Woller, Norman, Sarah Knocke, Bettina Mundt, et al.. (2011). Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. Journal of Clinical Investigation. 121(7). 2570–2582. 40 indexed citations
19.
Gürlevik, Engin, Norman Woller, Arnold Kloos, et al.. (2010). Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral Immunity. Molecular Therapy. 18(11). 1972–1982. 22 indexed citations
20.
Boozari, B, Bettina Mundt, Norman Woller, et al.. (2010). Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma. Gut. 59(10). 1416–1426. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Wenthe Breakdown of academic impact, for papers by Dirk M. van der Steen Breakdown of academic impact, for papers by Thomas Leemhuis Breakdown of academic impact, for papers by Tomoyuki Ogura Breakdown of academic impact, for papers by D Banerjee Breakdown of academic impact, for papers by Maxine Bauzon Breakdown of academic impact, for papers by Anthony F. Daniyan Breakdown of academic impact, for papers by Uxua Mancheño Breakdown of academic impact, for papers by Peter Buttgereit Breakdown of academic impact, for papers by Teresa Rasalan
Rankless by CCL
2026